Fingerprint
Dive into the research topics of 'Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): Results from the AML Study Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): Results from the AML Study Group
the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)
- University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
- Medical Faculty and University Hospital Düsseldorf
- Evangelisches Krankenhaus Essen-Werden
- University of Freiburg
- A Karl-Landsteiner Institute
- University Medical Center
- Städtisches Klinikum Karlsruhe
- Charité – Universitätsmedizin Berlin
- University Medical Center Hamburg-Eppendorf
- University Hospital Schleswig-Holstein
- University Children’s Hospital
- Knappschaftsknmkenhaus
- University of Bonn and University Hospital Bonn
- Magdeburg University Hospital
- Klinikum Braunschweig
- Heidelberg University
- Hannover Medical School
Research output: Contribution to journal › Article › peer-review
78
Scopus
citations